OBJECTIVES: The aims of this study were to: 1) assess the feasibility of left ventricular (LV) vortex flow analysis using contrast echocardiography (CE); and 2) characterize and quantify LV vortex flow in normal subjects and patients with LV systolic dysfunction. BACKGROUND: Vortices that form during LV filling have specific geometry and anatomical locations that are critical determinants of directed blood flow during ejection. Therefore, it is clinically relevant to assess the vortex flow patterns to better understand the LV function. METHODS: Twenty-five patients (10 normal and 15 patients with abnormal LV systolic function) underwent CE with intravenous contrast agent, Definity (Bristol-Myers Squibb Medical Imaging, Inc., North Billerica, Massachusetts). The velocity vector and vorticity were estimated by particle image velocimetry. Average vortex parameters including vortex depth, transverse position, length, width, and sphericity index were measured. Vortex pulsatility parameters including relative strength, vortex relative strength, and vortex pulsation correlation were also estimated. RESULTS: Vortex depth and vortex length were significantly lower in the abnormal LV function group (0.443 +/- 0.04 vs. 0.482 +/- 0.06, p < 0.05; 0.366 +/- 0.06 vs. 0.467 +/- 0.05, p < 0.01, respectively). Vortex width was greater (0.209 +/- 0.05 vs. 0.128 +/- 0.06, p < 0.01) and sphericity index was lower (1.86 +/- 0.5 vs. 3.66 +/- 0.6, p < 0.001) in the abnormal LV function group. Relative strength (1.13 +/- 0.4 vs. 2.10 +/- 0.8, p < 0.001), vortex relative strength (0.57 +/- 0.2 vs. 1.19 +/- 0.5, p < 0.001), and vortex pulsation correlation (0.63 +/- 0.2 vs. 1.31 +/- 0.5, p < 0.001) were significantly lower in the abnormal LV function group. CONCLUSIONS: It was feasible to quantify LV vorticity arrangement by CE using particle image velocimetry in normal subjects and those with LV systolic dysfunction, and the vorticity imaging by CE may serve as a novel approach to depict vortex, the principal quantity to assess the flow structure.
OBJECTIVES: The aims of this study were to: 1) assess the feasibility of left ventricular (LV) vortex flow analysis using contrast echocardiography (CE); and 2) characterize and quantify LV vortex flow in normal subjects and patients with LV systolic dysfunction. BACKGROUND: Vortices that form during LV filling have specific geometry and anatomical locations that are critical determinants of directed blood flow during ejection. Therefore, it is clinically relevant to assess the vortex flow patterns to better understand the LV function. METHODS: Twenty-five patients (10 normal and 15 patients with abnormal LV systolic function) underwent CE with intravenous contrast agent, Definity (Bristol-Myers Squibb Medical Imaging, Inc., North Billerica, Massachusetts). The velocity vector and vorticity were estimated by particle image velocimetry. Average vortex parameters including vortex depth, transverse position, length, width, and sphericity index were measured. Vortex pulsatility parameters including relative strength, vortex relative strength, and vortex pulsation correlation were also estimated. RESULTS: Vortex depth and vortex length were significantly lower in the abnormal LV function group (0.443 +/- 0.04 vs. 0.482 +/- 0.06, p < 0.05; 0.366 +/- 0.06 vs. 0.467 +/- 0.05, p < 0.01, respectively). Vortex width was greater (0.209 +/- 0.05 vs. 0.128 +/- 0.06, p < 0.01) and sphericity index was lower (1.86 +/- 0.5 vs. 3.66 +/- 0.6, p < 0.001) in the abnormal LV function group. Relative strength (1.13 +/- 0.4 vs. 2.10 +/- 0.8, p < 0.001), vortex relative strength (0.57 +/- 0.2 vs. 1.19 +/- 0.5, p < 0.001), and vortex pulsation correlation (0.63 +/- 0.2 vs. 1.31 +/- 0.5, p < 0.001) were significantly lower in the abnormal LV function group. CONCLUSIONS: It was feasible to quantify LV vorticity arrangement by CE using particle image velocimetry in normal subjects and those with LV systolic dysfunction, and the vorticity imaging by CE may serve as a novel approach to depict vortex, the principal quantity to assess the flow structure.
Authors: W Y Kim; P G Walker; E M Pedersen; J K Poulsen; S Oyre; K Houlind; A P Yoganathan Journal: J Am Coll Cardiol Date: 1995-07 Impact factor: 24.094
Authors: Morteza Gharib; Edmond Rambod; Arash Kheradvar; David J Sahn; John O Dabiri Journal: Proc Natl Acad Sci U S A Date: 2006-04-10 Impact factor: 11.205
Authors: S L Mulvagh; A N DeMaria; S B Feinstein; P N Burns; S Kaul; J G Miller; M Monaghan; T R Porter; L J Shaw; F S Villanueva Journal: J Am Soc Echocardiogr Date: 2000-04 Impact factor: 5.251
Authors: Lorenzo Rossini; Pablo Martinez-Legazpi; Vi Vu; Leticia Fernández-Friera; Candelas Pérez Del Villar; Sara Rodríguez-López; Yolanda Benito; María-Guadalupe Borja; David Pastor-Escuredo; Raquel Yotti; María J Ledesma-Carbayo; Andrew M Kahn; Borja Ibáñez; Francisco Fernández-Avilés; Karen May-Newman; Javier Bermejo; Juan C Del Álamo Journal: J Biomech Date: 2015-11-30 Impact factor: 2.712
Authors: Daniel Rodriguez Muñoz; Michael Markl; José Luis Moya Mur; Alex Barker; Covadonga Fernández-Golfín; Patrizio Lancellotti; José Luis Zamorano Gómez Journal: Eur Heart J Cardiovasc Imaging Date: 2013-08-01 Impact factor: 6.875
Authors: John J Charonko; Rahul Kumar; Kelley Stewart; William C Little; Pavlos P Vlachos Journal: Ann Biomed Eng Date: 2013-02-07 Impact factor: 3.934